These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25959171)

  • 1. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies.
    Xenopoulos A
    J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study.
    Xu J; Xu X; Huang C; Angelo J; Oliveira CL; Xu M; Xu X; Temel D; Ding J; Ghose S; Borys MC; Li ZJ
    MAbs; 2020 Jan; 12(1):1770669. PubMed ID: 32425110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and operation of a continuous integrated monoclonal antibody production process.
    Steinebach F; Ulmer N; Wolf M; Decker L; Schneider V; Wälchli R; Karst D; Souquet J; Morbidelli M
    Biotechnol Prog; 2017 Sep; 33(5):1303-1313. PubMed ID: 28691347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process cost and facility considerations in the selection of primary cell culture clarification technology.
    Felo M; Christensen B; Higgins J
    Biotechnol Prog; 2013; 29(5):1239-45. PubMed ID: 23847160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up.
    Girard V; Hilbold NJ; Ng CK; Pegon L; Chahim W; Rousset F; Monchois V
    J Biotechnol; 2015 Nov; 213():65-73. PubMed ID: 25962790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity.
    Kamga MH; Cattaneo M; Yoon S
    Prep Biochem Biotechnol; 2018 May; 48(5):383-390. PubMed ID: 29509101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm.
    Arnold L; Lee K; Rucker-Pezzini J; Lee JH
    Biotechnol J; 2019 Feb; 14(2):e1800061. PubMed ID: 29729129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production.
    Dizon-Maspat J; Bourret J; D'Agostini A; Li F
    Biotechnol Bioeng; 2012 Apr; 109(4):962-70. PubMed ID: 22094920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The business impact of an integrated continuous biomanufacturing platform for recombinant protein production.
    Walther J; Godawat R; Hwang C; Abe Y; Sinclair A; Konstantinov K
    J Biotechnol; 2015 Nov; 213():3-12. PubMed ID: 26014522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.
    Godawat R; Brower K; Jain S; Konstantinov K; Riske F; Warikoo V
    Biotechnol J; 2012 Dec; 7(12):1496-508. PubMed ID: 23070975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modular and multi-functional purification strategy that enables a common framework for manufacturing scale integrated and continuous biomanufacturing.
    Pybus LP; Heise C; Nagy T; Heeran C; Dover T; Raven J; Kori J; Burton G; Sakuyama H; Hastings B; Lyons M; Nakai S; Haigh J
    Biotechnol Prog; 2024; 40(4):e3456. PubMed ID: 38494903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process performance and product quality in an integrated continuous antibody production process.
    Karst DJ; Steinebach F; Soos M; Morbidelli M
    Biotechnol Bioeng; 2017 Feb; 114(2):298-307. PubMed ID: 27497430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of using continuous chromatography in downstream processing: Comparison of costs and product quality for a hybrid process vs. a conventional batch process.
    Ötes O; Flato H; Winderl J; Hubbuch J; Capito F
    J Biotechnol; 2017 Oct; 259():213-220. PubMed ID: 28684321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polishing approach with fully connected flow-through purification for therapeutic monoclonal antibody.
    Ichihara T; Ito T; Gillespie C
    Eng Life Sci; 2019 Jan; 19(1):31-36. PubMed ID: 32624953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment.
    Ding C; Ardeshna H; Gillespie C; Ierapetritou M
    Biotechnol Bioeng; 2022 Dec; 119(12):3567-3583. PubMed ID: 36109341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous and Integrated Expression and Purification of Recombinant Antibodies.
    Vogg S; Wolf MKF; Morbidelli M
    Methods Mol Biol; 2018; 1850():147-178. PubMed ID: 30242686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal Antibodies Production Platforms: An Opportunity Study of a Non-Protein-A Chromatographic Platform Based on Process Economics.
    Grilo AL; Mateus M; Aires-Barros MR; Azevedo AM
    Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28901658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of a three step mAb chromatography process from batch to continuous: Optimizing productivity to minimize consumable requirements.
    Gjoka X; Gantier R; Schofield M
    J Biotechnol; 2017 Jan; 242():11-18. PubMed ID: 27939321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.